Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Divalent-platinum complex containing sterically-hindered aryl group and preparation method and application thereof

A technology of platinum complexes and groups, applied in the field of anti-tumor platinum complexes, can solve the problems of toxicity, limited application of platinum drugs, drug resistance, etc.

Inactive Publication Date: 2013-06-12
SOUTHEAST UNIV
View PDF3 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, this type of platinum drug has some defects: one is the corresponding toxicity, mainly kidney toxicity and bone marrow toxicity; the other is drug resistance after drug use
These deficiencies limit the application of these platinum drugs to a certain extent

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Divalent-platinum complex containing sterically-hindered aryl group and preparation method and application thereof
  • Divalent-platinum complex containing sterically-hindered aryl group and preparation method and application thereof
  • Divalent-platinum complex containing sterically-hindered aryl group and preparation method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0033] The preparation of embodiment 1. complex 1 (molecular formula: C 13 h 20 Cl 2 N 2 Pt)

[0034]

[0035] Potassium tetrachloroplatinate (5.00mmol) and ligand (N-benzyl-1R, 2R-cyclohexanediamine, 5.00mmol) were mixed in 80mL of water, stirred at 30°C for 24 hours in the dark, a large amount of yellow precipitate Generated, filtered, washed repeatedly with water, washed with a small amount of ethanol, dried to obtain yellow powder, yield: 86%. IR(KBr,cm -1 ):3466(br),3120,2935,2860,1580,1452,751,702; 1 H-NMR (d 6 -DMSO / TMS,ppm):δ1.09-2.01(m,8H,CH 2 of DACH),δ2.12-2.25(m,2H,NHCH and NH 2 CH),δ3.91-4.54(m,2H,NHCH 2Ph),δ6.11-6.16(dd,2H,CHNH 2 ),δ7.29-7.31(m,1H,CH 2 NH), δ7.38-8.11(m, 5H, Ar-H); ESI-MS: m / z[M-Cl] + =435(100%).

Embodiment 2

[0038] Embodiment 2. The preparation of complex 2 (molecular formula: C 13 h 19 Cl 2 FN 2 Pt)

[0039]

[0040] Prepared with reference to the method described in Example 1, the ligand is N-(2-fluorobenzyl)-1R,2R-cyclohexanediamine, the reaction temperature is 50°C, and it is stirred for 24 hours in the dark to obtain a light yellow powder. The yield is: 97%. IR(KBr,cm -1 ):3138(br),2933,2862,1579,1494,1451,1229,1187,1139,763; 1 H-NMR (d 6 -DMSO / TMS,ppm):δ0.80-1.85(m,8H,CH 2 of DACH),δ2.11-2.23(m,2H,NHCH and NH 2 CH),δ3.89-4.40(m,2H,NHCH 2 Ph),δ4.96-5.47(dd,2H,CHNH 2 ), δ6.75-7.45(m, 4H, Ar-H), δ8.89-8.93(m, 1H, CH 2 NH); ESI-MS: m / z [M-Cl] + =453(100%).

Embodiment 3

[0041] The preparation of embodiment 3. complex 3 (molecular formula: C 13 h 19 Cl 2 FN 2 Pt)

[0042]

[0043] Prepared with reference to the method described in Example 1, the ligand is N-(3-fluorobenzyl)-1R,2R-cyclohexanediamine, the reaction temperature is 60°C, and it is stirred for 12 hours in the dark to obtain a light yellow powder. The yield is: 85%. IR(KBr,cm -1 ):3267(br),3188,3100,2938,1587,1451,1258,1147,791,753; 1 H NMR (d 6 -DMSO / TMS,ppm):δ0.76-1.98(m,8H,CH 2 of DACH),δ1.98-2.23(m,2H,NHCH and NH 2 CH),δ3.67-4.58(m,2H,NHCH2Ph),δ5.01-5.48(dd,2H,CHNH 2 ), δ6.72-7.86(m, 4H, Ar-H), δ8.25-8.27(m, 1H, CH 2 NH); ESI-MS: m / z [M-Cl] + =453(100%).

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses an antitumor platinum (II) complex which takes a chiral trans-1, 2-cyclohexanediamine derivative containing a sterically-hindered aryl group as a ligand. The antitumor platinum (II) complex has a structural formula I or II, wherein in the structural formula I, X is H, OCH3 or F and is in the ortho, meta or para position of N-methylene in a benzene ring, in the structural formula II, X is H, OCH3 or F and is in the ortho, meta or para position of N-methylene in a benzene ring, Z is oxalate, malonate, 1, 1-cyclobutyl diacid radical or 3-hydroxy-1, 1-cyclobutyl diacid radical. Two chiral carbon atoms in the trans-1, 2-cyclohexanediamine group have the same three-dimensional configuration and are both in the R or S configuration. The invention also discloses a preparation method of the platinum complex and an application of the platinum complex to the preparation of an anti-tumor medicament.

Description

technical field [0001] The present invention relates to anti-tumor platinum complexes, in particular to anti-tumor platinum (II) complexes with chiral trans-1,2-cyclohexanediamine derivatives containing aryl hindering groups as ligands, and to anti-tumor platinum (II) complexes The preparation method and application of the platinum complex. Background technique [0002] Several anti-tumor platinum drugs including cisplatin, carboplatin and oxaliplatin have been widely used clinically for the treatment of related cancers. However, this type of platinum drug has some defects: first, it exhibits corresponding toxicity, mainly kidney toxicity and bone marrow toxicity; second, it develops drug resistance after administration. These deficiencies limit the application of these platinum drugs to some extent. [0003] In the past ten years, based on the in-depth understanding of the resistance mechanism of platinum complexes, the research on platinum drugs is no longer limited to t...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07F15/00A61K31/282A61P35/00
CPCA61K31/282C07F15/00A61K31/555A61P35/00C07F15/0093
Inventor 苟少华
Owner SOUTHEAST UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com